Rafael Holdings Inc - Ordinary Shares - Class B

NYSE:RFL   3:59:55 PM EDT
50.42
-1.54 (-2.96%)
Products

FDA Grants Rafael Pharmaceuticals Orphan Drug Designation For Devimistat

Published: 06/29/2021 17:25 GMT
Rafael Holdings Inc - Ordinary Shares - Class B (RFL) - FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for Cpi-613® (devimistat) for Treatment of Biliary Cancer.